An oral nanocombinatorial agent exhibits pleiotropic improvement in diabetic nephropathy via modulation of the SCAP/SREBPs pathway

Abstract The multifaceted pathogenesis and multi-cellular involvement of diabetic nephropathy (DN) stand in stark contrast to the inadequacy of conventional single-target therapeutic strategies. This disparity underscores the urgent need for novel drugs with comprehensive targeting capabilities. Her...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yu Su, Haobo Wen, Ke Hu, Cuiping Wen, Ping Wang, Lulu Zhao, Gang Zou, Wei Jiang, Yaxi Chen, Yunfei Zhao, Qiu Li
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2026-03-01
Цуврал:	Journal of Nanobiotechnology
Нөхцлүүд:	Diabetic nephropathy SCAP/SREBPs Lipid metabolic disorders Inflammation Lycorine Oral delivery
Онлайн хандалт:	https://doi.org/10.1186/s12951-026-04301-9
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!